Cargando…
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
BACKGROUND: In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction. DNA methylation markers have been proven to be of...
Autores principales: | de Ruijter, Tim C., van der Heide, Frank, Smits, Kim M., Aarts, Maureen J., van Engeland, Manon, Heijnen, Vivianne C. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993426/ https://www.ncbi.nlm.nih.gov/pubmed/32005275 http://dx.doi.org/10.1186/s13058-020-1250-9 |
Ejemplares similares
-
The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study
por: de Ruijter, Tim C., et al.
Publicado: (2019) -
Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010) -
Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers
por: Joosten, S. C., et al.
Publicado: (2021) -
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018) -
Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC
por: Rademakers, Glenn, et al.
Publicado: (2021)